GlassScriptPhysician profile
Co Dl Pham
NPI 1558392159
$2,443.28
in general payments reported to CMS, 2019-2025
26 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $198 · 2021: $559 · 2022: $196 · 2023: $76.28 · 2024: $164 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.51 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $462.10 | 2019-2022 | |
| Amgen INC. | $331.41 | 2019-2025 | Evenity, Prolia, Repatha |
| Amarin Pharma, INC. | $260.69 | 2019-2022 | |
| Abbvie INC. | $221.59 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $202.51 | 2019-2025 | Breztri |
| Astellas Pharma US INC | $151.98 | 2021-2024 | |
| Novo Nordisk INC | $115.36 | 2021 | |
| Merck Sharp & Dohme LLC | $114.16 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.00 | 2019 | |
| Lilly USA, LLC | $98.81 | 2019 | |
| Covidien LP | $74.26 | 2019 | |
| Aspira Women'S Health INC | $50.51 | 2021 | |
| Genentech USA, INC. | $28.95 | 2020-2021 | |
| Coopersurgical, INC. | $25.02 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $24.29 | 2025 | Voquezna |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $23.04 | 2021 | |
| Agile Therapeutics, INC. | $21.16 | 2022 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Myovant Sciences INC. | $15.31 | 2021 | |
| Exact Sciences Corporation | $15.04 | 2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $14.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.89 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.80 | 2019 | |
| Radius Health, INC. | $12.92 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.10 | 2019 | |
| Mayne Pharma Commercial LLC | $11.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Co Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.